Does HALOPERIDOL Cause Malignant neoplasm progression? 9 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Malignant neoplasm progression have been filed in association with HALOPERIDOL (Haloperidol). This represents 0.1% of all adverse event reports for HALOPERIDOL.
9
Reports of Malignant neoplasm progression with HALOPERIDOL
0.1%
of all HALOPERIDOL reports
9
Deaths
7
Hospitalizations
How Dangerous Is Malignant neoplasm progression From HALOPERIDOL?
Of the 9 reports, 9 (100.0%) resulted in death, 7 (77.8%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HALOPERIDOL. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does HALOPERIDOL Cause?
Drug ineffective (1,771)
Neuroleptic malignant syndrome (1,244)
Off label use (1,136)
Toxicity to various agents (872)
Extrapyramidal disorder (838)
Somnolence (712)
Intentional self-injury (636)
Drug interaction (596)
Weight increased (583)
Tremor (579)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which HALOPERIDOL Alternatives Have Lower Malignant neoplasm progression Risk?
HALOPERIDOL vs HALOPERIDOL DECANOATE
HALOPERIDOL vs HECTOROL
HALOPERIDOL vs HEMIN
HALOPERIDOL vs HEPARIN
HALOPERIDOL vs HEPARIN\SODIUM